Skip to content
Moroxite F logo — Developing next generation therapeutics in osteoporosis.

Moroxite F

Developing next generation therapeutics in osteoporosis.

Founded 2021 Sweden Sweden 10 employees Venture round Total: $10.00M Health Care, Health and Wellness

General Information

Company Name Moroxite F
Founded Year 2021
Location Sweden Sweden
Employees 10
Industries Health Care, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Moroxite F. To contact Moroxite F, visit moroxitef.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Moroxite F compare?

A PDF of Moroxite F and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Moroxite F soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Moroxite F

Moroxite F is a med-tech company founded in 2021 and based in Sweden with the slogan "Developing next generation therapeutics in osteoporosis." The company is dedicated to developing a regenerative medicine approach to improve implant anchorage in fragile bone and reduce re-operations. Their innovative approach involves a biphasic ceramic material containing apatite particles, a novel drug delivery method to augment fracture fixation, and an effective device. The company recently secured a significant kr10.00M Venture Round investment on 18 February 2022 from Almi Invest and Fåhraeus Startup and Growth. With its focus on addressing critical needs within the Health Care industry, Moroxite F exhibits potential in revolutionizing osteoporosis treatment and enhancing the overall quality of care for patients.

Business keywords: regenerative medicine, med-tech, osteoporosis, fracture fixation, implant anchorage, biphasic ceramic material, apatite particles, drug delivery, device, osteoporotic fracture treatment, implant technology, biomedical engineering, orthopedics, biomaterials

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round kr10.00M 2
Almi Invest, Fåhraeus Startup and Growth
18 Feb 2022

Moroxite F Alternatives & Competitors

View All Alternatives
Moroxite F vs

Clinical stage biotechnology company developing novel medicines that selectively distribute to the i...

Venture round
15 employees
Biotechnology, Health Care
Moroxite F vs

Restoring health to improve the quality of life for patients with bone disorders.

Post-IPO Equity
163 employees
Biotechnology, Health Care
Moroxite F vs
CoNextions Medical
CoNextions Medical United States

Revolutionizing Tendon Repair

Venture round
17 employees
Health Care, Health and Wellness

FAQ About Moroxite F

Developing next generation therapeutics in osteoporosis.
Moroxite F was founded in 2021.
Moroxite F is headquartered in Sweden.
Moroxite F operates in Health Care and Health and Wellness. Its work centres on regenerative medicine, med-tech, osteoporosis and fracture fixation.
Moroxite F has approximately 10 employees.
Moroxite F has completed 1 funding round, raising a total of $10.00M. The latest funding stage is Venture round.
Top alternatives and competitors to Moroxite F include Mesentech, BONESUPPORT AB, CoNextions Medical, Sentien Biotechnologies, Inc., ReNeuron Group Plc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Moroxite F and Mesentech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Moroxite F, https://bouncewatch.com/company/moroxite-f, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout